We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.69%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.01B
(+12%)
Cap. Flow
+$2.13B
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
2,400
New
147
Increased
1,057
Reduced
1,017
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$295M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$119M |
| 3 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$110M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$103M |
| 5 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$95.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$182M |
| 2 |
Edgewell Personal Care
EPC
|
+$107M |
| 3 |
Hain Celestial
HAIN
|
+$92.5M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$86.9M |
| 5 |
PDLI
PDL BioPharma, Inc.
PDLI
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.14% |
| 2 | Consumer Discretionary | 10.55% |
| 3 | Technology | 10.47% |
| 4 | Consumer Staples | 9.74% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
VeriSign
VRSN
$23.8B
| $127M | 0.33% |
1,459,117
+357,626
| +32% | +$29.8M |
|
52
United Therapeutics
UTHR
$26.4B
| $127M | 0.33% |
808,136
-264,790
| -25% | -$38.5M |
|
53
Biogen
BIIB
$29.6B
| $125M | 0.33% |
408,831
-49,469
| -11% | -$14.2M |
|
54
Vertex Pharmaceuticals
VRTX
$120B
| $123M | 0.32% |
979,725
-43,619
| -4% | -$5.27M |
|
55
BioMarin Pharmaceuticals
BMRN
$11.4B
| $123M | 0.32% |
1,172,317
-295,520
| -20% | -$30.9M |
|
|
FNI
56
DELISTED
First Trust Chindia ETF
FNI
| $122M | 0.32% |
4,286,401
-76,619
| -2% | -$2.14M |
|
57
Ingredion
INGR
$6.32B
| $121M | 0.31% |
1,263,634
-99,077
| -7% | -$9.39M |
|
58
ExxonMobil
XOM
$650B
| $118M | 0.31% |
1,510,059
-6,612
| -0.4% | -$529K |
|
59
AT&T
T
$157B
| $118M | 0.3% |
4,521,316
+343,629
| +8% | +$8.72M |
|
|
ETFC
60
DELISTED
E*Trade Financial Corporation
ETFC
| $117M | 0.3% |
3,961,288
+972,630
| +33% | +$28M |
|
61
Celldex Therapeutics
CLDX
$2.78B
| $116M | 0.3% |
494,961
+174,302
| +54% | +$38M |
|
62
Flowers Foods
FLO
$1.64B
| $116M | 0.3% |
5,410,509
+2,912,467
| +117% | +$70.9M |
|
63
Alnylam Pharmaceuticals
ALNY
$35.9B
| $115M | 0.3% |
1,223,535
-338,836
| -22% | -$31.4M |
|
|
FHK
64
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
| $115M | 0.3% |
3,419,133
-61,111
| -2% | -$2.1M |
|
65
Cisco
CSCO
$444B
| $115M | 0.3% |
4,231,012
+132,727
| +3% | +$3.66M |
|
|
MDVN
66
DELISTED
MEDIVATION, INC.
MDVN
| $114M | 0.3% |
2,360,636
-221,962
| -9% | -$9.58M |
|
67
Myriad Genetics
MYGN
$538M
| $114M | 0.3% |
2,642,163
-1,037,416
| -28% | -$43.8M |
|
68
Novavax
NVAX
$1.29B
| $113M | 0.29% |
676,282
+142,838
| +27% | +$22M |
|
69
Pilgrim's Pride
PPC
$6.64B
| $113M | 0.29% |
5,118,960
+639,333
| +14% | +$13.1M |
|
|
CPHD
70
DELISTED
Cepheid Inc
CPHD
| $113M | 0.29% |
3,085,311
+1,048,552
| +51% | +$37.3M |
|
|
AMTD
71
DELISTED
TD Ameritrade Holding Corp
AMTD
| $113M | 0.29% |
3,245,138
+717,557
| +28% | +$24.9M |
|
|
QGENF
72
DELISTED
QIAGEN NV
QGENF
| $112M | 0.29% |
4,068,344
-658,303
| -14% | -$18.2M |
|
73
Baxter International
BAX
$11.2B
| $108M | 0.28% |
2,823,783
+2,524,936
| +845% | +$92.3M |
|
|
MDRX
74
DELISTED
Veradigm Inc. Common Stock
MDRX
| $105M | 0.27% |
6,809,932
+3,590,772
| +112% | +$51.5M |
|
75
Herbalife
HLF
$1.22B
| $105M | 0.27% |
3,899,136
+1,103,816
| +39% | +$30.7M |
|
Similar funds
DAM
First Trust Advisors's Q4 2015 Portfolio in Review
As of Q4 2015, First Trust Advisors held 2,400 positions worth $38.5B, up 12% from $34.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
First Trust Advisors deployed $2.13B of net new capital in Q4 2015, opening 147 new positions and adding to 1,057 existing holdings. Its largest new stake was Alphabet (Google) Class A: 7,974,380 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $182M trimmed.
- First Trust Advisors's largest Q4 2015 buy was Alphabet (Google) Class A: 7,974,380 shares worth $310M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q4 2015, an estimated $110M increase.
- First Trust Advisors's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $182M.
- First Trust Advisors fully exited Edgewell Personal Care in Q4 2015, selling an estimated $107M.
- First Trust Advisors's ten largest holdings make up 18% of its $38.5B portfolio in Q4 2015.
- First Trust Advisors opened 147 new positions and closed 171 in Q4 2015.
- First Trust Advisors's portfolio value rose 12% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q4 2015, filed 3 Feb 2016.